Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colonic glibenclamide or glucose perfusion to assess GLP-1 release in type 2 diabetes
ACTRN12613000843752Phase 4Not yet recruiting
- Sponsor
- Dr. Nam Q Nguyen
- Start
- Sep 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of glibenclamide and glucose in type 2 diabetes mellitus (T2DM), sponsored by Dr. Nam Q Nguyen. Planned start Sep 2013; status: not yet recruiting.
02
Drugs
glibenclamideglucose
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ACTRN12613000843752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000843752.